FULC vs. TRTN-PA

Last updated Jun 4, 2026

FULC (Fulcrum Therapeutics, Inc.) and TRTN-PA (Triton International Ltd) are both stocks. FULC operates in Biotechnology (Healthcare), while TRTN-PA operates in Rental & Leasing Services (Industrials). Over the past 5 years, FULC returned -18.10%/yr vs 6.54%/yr for TRTN-PA. At a 0.11 correlation, their price movements are largely independent.

Performance

FULC vs. TRTN-PA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fulcrum Therapeutics, Inc. (FULC) and Triton International Ltd (TRTN-PA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, FULC achieves a -71.53% return, which is significantly lower than TRTN-PA's 3.14% return.

FULC

• 1D: 2.55%
• 1M: -54.13%
• YTD: -71.53%
• 6M: -64.46%
• 1Y: -54.23%
• 3Y*: 1.60%
• 5Y*: -18.10%
• 10Y*: —

TRTN-PA

• 1D: -0.61%
• 1M: 0.50%
• YTD: 3.14%
• 6M: 3.49%
• 1Y: 10.31%
• 3Y*: 8.59%
• 5Y*: 6.54%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

FULC vs. TRTN-PA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
FULC Fulcrum Therapeutics, Inc.	-71.53%	140.64%	-30.37%	-7.28%	-58.85%	51.07%	-29.63%	23.26%
TRTN-PA Triton International Ltd	3.14%	9.17%	10.10%	8.47%	-0.37%	8.71%	7.39%	7.16%

Correlation

The correlation between FULC and TRTN-PA is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.07
Correlation (3Y) Calculated over the trailing 3-year period	0.01
Correlation (5Y) Calculated over the trailing 5-year period	0.07
Correlation (All Time) Calculated using the full available price history since Jul 19, 2019	0.11

The correlation between FULC and TRTN-PA shifts across timeframes, from 0.01 (3 years) to 0.11 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap FULC : $245.41M TRTN-PA : $2.62B
EPS FULC : -$1.15 TRTN-PA : $4.65
PB Ratio FULC : 0.74 TRTN-PA : 1.64
Total Revenue (TTM) FULC : $0.00 TRTN-PA : $1.35B
Gross Profit (TTM) FULC : $0.00 TRTN-PA : $872.64M
EBITDA (TTM) FULC : -$78.37M TRTN-PA : $1.11B

Return for Risk

FULC vs. TRTN-PA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FULC

FULC Risk / Return Rank: 16
FULC Sharpe Ratio Rank: 18
FULC Sortino Ratio Rank: 23
FULC Omega Ratio Rank: 22
FULC Calmar Ratio Rank: 16
FULC Martin Ratio Rank: 2

TRTN-PA

TRTN-PA Risk / Return Rank: 81
TRTN-PA Sharpe Ratio Rank: 80
TRTN-PA Sortino Ratio Rank: 74
TRTN-PA Omega Ratio Rank: 75
TRTN-PA Calmar Ratio Rank: 85
TRTN-PA Martin Ratio Rank: 91

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FULC vs. TRTN-PA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fulcrum Therapeutics, Inc. (FULC) and Triton International Ltd (TRTN-PA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	FULC	TRTN-PA	Difference
Sharpe ratio Return per unit of total volatility	-0.55	1.40	-1.94
Sortino ratio Return per unit of downside risk	-0.34	1.94	-2.28
Omega ratio Gain probability vs. loss probability	0.95	1.26	-0.31
Calmar ratio Return relative to maximum drawdown	-0.69	3.53	-4.22
Martin ratio Return relative to average drawdown	-1.81	13.19	-14.99
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

FULC vs. TRTN-PA - Sharpe Ratio Comparison

The current FULC Sharpe Ratio is -0.55, which is lower than the TRTN-PA Sharpe Ratio of 1.40. The chart below compares the historical Sharpe Ratios of FULC and TRTN-PA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	FULC	TRTN-PA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.55	1.40	-1.94
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.16	0.75	-0.91
Sharpe Ratio (All Time) Calculated using the full available price history	-0.17	0.41	-0.58

Drawdowns

FULC vs. TRTN-PA - Drawdown Comparison

The maximum FULC drawdown since its inception was -92.70%, which is greater than TRTN-PA's maximum drawdown of -57.11%. Use the drawdown chart below to compare losses from any high point for FULC and TRTN-PA.

Drawdown Indicators

	FULC	TRTN-PA	Difference
Max Drawdown Largest peak-to-trough decline	-92.70%	-57.11%	-35.59%
Max Drawdown (1Y) Largest decline over 1 year	-78.49%	-2.93%	-75.56%
Max Drawdown (3Y) Largest decline over 3 years	-79.08%	-3.54%	-75.54%
Max Drawdown (5Y) Largest decline over 5 years	-92.70%	-7.48%	-85.22%
Current Drawdown Current decline from peak	-89.60%	-0.88%	-88.72%
Average Drawdown Average peak-to-trough decline	-62.65%	-2.32%	-60.33%
Ulcer Index Depth and duration of drawdowns from previous peaks	30.01%	0.78%	+29.23%

Volatility

FULC vs. TRTN-PA - Volatility Comparison

Fulcrum Therapeutics, Inc. (FULC) has a higher volatility of 73.43% compared to Triton International Ltd (TRTN-PA) at 2.11%. This indicates that FULC's price experiences larger fluctuations and is considered to be riskier than TRTN-PA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FULC	TRTN-PA	Difference
Volatility (1M) Calculated over the trailing 1-month period	73.43%	2.11%	+71.32%
Volatility (6M) Calculated over the trailing 6-month period	95.79%	5.16%	+90.63%
Volatility (1Y) Calculated over the trailing 1-year period	99.47%	7.42%	+92.05%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	111.24%	8.80%	+102.44%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	111.94%	21.36%	+90.58%

Dividends

FULC vs. TRTN-PA - Dividend Comparison

FULC has not paid dividends to shareholders, while TRTN-PA's dividend yield for the trailing twelve months is around 8.21%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019
FULC Fulcrum Therapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
TRTN-PA Triton International Ltd	8.21%	8.30%	8.33%	8.45%	8.43%	7.75%	7.81%	5.80%

Financials

Frequently Asked Questions

Can I hold both FULC and TRTN-PA in my portfolio?

FULC and TRTN-PA have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, FULC or TRTN-PA?

FULC has higher volatility (73.43%) compared to TRTN-PA (2.11%). In terms of maximum drawdown, FULC dropped -92.70% vs TRTN-PA's -57.11%.

Which has better risk-adjusted returns?

TRTN-PA currently has the higher Sharpe Ratio (1.40 vs -0.55), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.